CoreCap Advisors’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.81K | Hold |
140
| – | – | ﹤0.01% | 2016 |
|
|
2025
Q1 | $4.76K | Buy |
140
+34
| +32% | +$1.16K | ﹤0.01% | 2109 |
|
|
2024
Q4 | $4.17K | Sell |
106
-137
| -56% | -$5.39K | ﹤0.01% | 2012 |
|
|
2024
Q3 | $11.4K | Hold |
243
| – | – | ﹤0.01% | 1751 |
|
|
2024
Q2 | $13.1K | Hold |
243
| – | – | ﹤0.01% | 1006 |
|
|
2024
Q1 | $16.6K | Buy |
+243
| New | +$16.6K | ﹤0.01% | 1564 |
|
|
2022
Q4 | $2.15K | Buy |
+53
| New | +$2.15K | ﹤0.01% | 1926 |
|
|
2022
Q3 | – | Sell |
-95
| Closed | -$6K | – | 850 |
|
|
2022
Q2 | $6K | Buy |
+95
| New | +$6K | ﹤0.01% | 1605 |
|
|
2022
Q1 | – | Sell |
-42
| Closed | -$3K | – | 859 |
|
|
2021
Q4 | $3K | Buy |
+42
| New | +$3K | ﹤0.01% | 1860 |
|